Владислав Матреницький та Дар’я Шапошник-Домінська прийняли учать у великій зустрічи...
At the EXPIO Center, we seek to better understand the nature of trauma experienced during war and its impact on mental health. Together with the NGO "Foundation for the Development of Medicine and Psychosocial Support", we are initiating a clinical trial to develop an effective treatment for post-traumatic stress disorder (PTSD) and anxiety-depressive states in veterans and civilians who do not respond to traditional methods of therapy.
"A single-center, randomized, double-blind, placebo-controlled clinical trial of ketamine-assisted integrative psychotherapy in military personnel with treatment-resistant PTSD"
Veterans or active military personnel (of any gender), ages 18–55, who have experienced military trauma and have a diagnosis of treatment-resistant PTSD are invited to participate.
Participation in the study is free for everyone who meets the selection criteria.
The duration of the therapeutic stage is 4–5 weeks.
Participants will be randomly divided into two groups:
The experimental group will receive ketamine 0.5 mg/kg intravenously twice a week + integrative psychotherapy sessions.
Control group — midazolam twice a week + identical psychotherapy.
Group rotation: After the first phase, control group participants who did not show significant improvement will be able to undergo ketamine therapy.
level of PTSD, depression, and anxiety symptoms;
quality of life;
general functioning.
Ketamine is a well-known medical drug with a 40-year history of use as an anesthetic.
In small doses, it has a strong psychotherapeutic effect .
In 2019, the FDA approved it for the treatment of treatment-resistant depression.
Studies prove the effectiveness of ketamine in treating PTSD — even a single injection can produce rapid and long-lasting effects.
When combined with psychotherapy, its effectiveness increases significantly.
The study was approved by the ethics committee of the Ukrainian Institute of Public Health Policy .
All information will be kept confidential .
The data may only be used for scientific purposes in an anonymized form .
Providing contact and basic personal data.
Signing informed consent.
Filling out psychological questionnaires (≈ 45 min).
Medical examination and tests (at the beginning and end).
Visiting the center 3 times a week for 2–3 hours (day hospital).
Permission to contact you in 3–6–12 months to assess long-term effects.
Permission to anonymously share data with other scientific organizations.
📩 If you meet the criteria and are ready to participate, fill out the form below .
📞 If you have any questions, contact us by phone: 07373 080 88
We invite sponsors, philanthropists, and activists to support our research into innovative trauma treatment methods! Make a donation HERE .
Help in restoring psychological balance and resource.
Dealing with anxiety, physical symptoms, and fear of losing control
Modern methods of overcoming fears that prevent you from living.
Therapy for people with post-traumatic stress disorder.
Порушення здоров’я, яке виникає через соматизацію, тобто «втілення» негативних емоцій у тілі.
Психоонкологія — це психотерапевтична допомога пацієнтам, які хворіють на рак.
Владислав Матреницький та Дар’я Шапошник-Домінська прийняли учать у великій зустрічи...
We are always open to communication. Contact us - we will answer all your questions and help you find the right solution.
Expio in Kyiv
Expio in Lviv
Ліцензія МОЗ України: наказ №1443 від 11.08.2023. Ліцензія ДержЛікСлужби України: наказ № 1065 від 11.07.2024
(з 2018 по 2024 р. наказ ДЛС від 25.10.2018 на ФОП Матреницький В.Л.)
© Expio 2025 All rights reserved. / Developed by Bereshkaweb